Multiple Sclerosis Research Today is a free monthly online journal that collates and summarizes the latest research about Multiple Sclerosis, including details on diagnosis, symptoms, treatment, prognosis.

Volume 5 (2008), Issue 10 (October)

1. CD4+CD25+FoxP3+PD1- regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy.
   FASEB J, 22(10): 3500-8. [Abstract] [Full-text]
2. Use of perfusion- and diffusion-weighted imaging in differential diagnosis of acute and chronic ischemic stroke and multiple sclerosis.
   Neurol Res, 30(8): 816-26. [Abstract] [Full-text]
3. The intricate interface between immune and metabolic regulation: a role for leptin in the pathogenesis of multiple sclerosis?
   J Leukoc Biol, 84(4): 893-9. [Abstract] [Full-text]
4. Retinal peripapillary nerve fiber layer thickness in neuromyelitis optica.
   Invest Ophthalmol Vis Sci, 49(10): 4412-7. [Abstract] [Full-text]
5. Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults.
   Neurology, 71(15): 1142-6. [Abstract] [Full-text]
6. Dose comparison trial of sustained-release fampridine in multiple sclerosis.
   Neurology, 71(15): 1134-41. [Abstract] [Full-text]
7. Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis.
   Blood, 112(8): 3383-90. [Abstract] [Full-text]
8. The Swedish occupational fatigue inventory in people with multiple sclerosis.
   J Rehabil Med, 40(9): 737-43. [Abstract] [Full-text]
9. FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis.
   Neurology, 71(16): 1261-7. [Abstract] [Full-text]
10. Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis.
    J Leukoc Biol, 84(5): 1248-55. [Abstract] [Full-text]
11. Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis.
    Neurology, 71(17): 1350-4. [Abstract] [Full-text]
12. The effects of interferon beta-1a on proton MR spectroscopic imaging in patients with multiple sclerosis, a controlled study, preliminary results.
    Int J Neurosci, 118(12): 1645-58. [Abstract] [Full-text]
13. Dendritic cells loaded with apoptotic oligodendrocytes as a source of myelin T-cell epitopes in multiple sclerosis.
    Clin Immunol, 129(2): 286-94. [Abstract] [Full-text]
14. Effectiveness of rehabilitation intervention in persons with multiple sclerosis: a randomised controlled trial.
    J Neurol Neurosurg Psychiatry, 79(11): 1230-5. [Abstract] [Full-text]
15. Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis.
    J Neurol Neurosurg Psychiatry, 79(11): 1224-9. [Abstract] [Full-text]
16. Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease.
    J Neurol Neurosurg Psychiatry, 79(11): 1245-8. [Abstract] [Full-text]
17. Regional grey matter atrophy in clinically isolated syndromes at presentation.
    J Neurol Neurosurg Psychiatry, 79(11): 1236-44. [Abstract] [Full-text]
18. Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.
    N Engl J Med, 359(17): 1786-801. [Abstract] [Full-text]
19. Effect of treatment with methylprednisolone on the serum levels of IL-12, IL-10 and CCL2 chemokine in patients with multiple sclerosis in relapse.
    Clin Neurol Neurosurg, 110(10): 992-6. [Abstract] [Full-text]
20. Multiple sclerosis.
    Lancet, 372(9648): 1502-17. [Abstract] [Full-text]
21. Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
    Lancet, 372(9648): 1463-72. [Abstract] [Full-text]
22. Novel therapeutic strategies for multiple sclerosis--a multifaceted adversary.
    Nat Rev Drug Discov, 7(11): 909-25. [Abstract] [Full-text]

© 2004-2012 Multiple Sclerosis Research Today. All Rights Reserved.